{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:55Z","timestamp":1786120315476,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Our aim was to determine the prevalence and risk factors associated with low bone mineral density (BMD) in vertically HIV-infected patients and to investigate whether low BMD is related to immune activation and senescence induced by HIV infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A cross-sectional study was performed in 98 vertically HIV-infected patients. BMD was measured by dual-energy radiograph absorptiometry at lumbar spine. Height adjustment of BMD Z score was performed using height-for-age Z score. T-cell immune activation and senescence were analyzed in a subgroup of 54 patients by flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Median age was 15.9 years, 71.4% were Caucasian, 99% received antiretroviral therapy and 80.6% had undetectable viral load. Low BMD (BMD Z score \u2264 \u22122) was present in 15.3% of cases, but after height adjustment in 4.1% of cases. Height-adjusted BMD Z score was positively correlated with body mass index Z score, CD4\/CD8 ratio and nadir CD4, and inversely with duration of severe immunosuppression and parathyroid hormone values. In the multivariate model including age, gender, ethnicity, encephalopathy, Tanner stage, nadir CD4, duration of viral suppression, CD4 count, CD4\/CD8 ratio, body mass index, cumulative duration of antiretroviral therapy, tenofovir and protease inhibitors exposure, nadir CD4 was independently associated to height-adjusted BMD Z score. No association was found between height-adjusted BMD Z score and T-cell activation or senescence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The prevalence of low BMD in vertically HIV-infected patients was low after height adjustment. Nadir CD4, but not T-cell activation or senescence, was an independent predictor for low BMD. Larger and prospective studies are needed to achieve better knowledge of the pathogenesis of low BMD in vertical HIV infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000001506","type":"journal-article","created":{"date-parts":[[2016,12,24]],"date-time":"2016-12-24T20:20:16Z","timestamp":1482610816000},"page":"578-583","source":"Crossref","is-referenced-by-count":18,"title":["Low Bone Mineral Density in Vertically HIV-infected Children and Adolescents"],"prefix":"10.1097","volume":"36","author":[{"given":"Beatriz","family":"Jim\u00e9nez","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal\u00eda","family":"Sainz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"D\u00edaz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Mellado","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Luisa","family":"Navarro","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rojo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"Gonz\u00e1lez-Tom\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Prieto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Isabel","family":"de Jos\u00e9","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Tom\u00e1s","family":"Ramos","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda \u00c1ngeles","family":"Mu\u00f1oz-Fernandez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Hospital Universitario Ni\u00f1o Jes\u00fas, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review.","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006.","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis"},{"key":"R3-20230912","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI117034","article-title":"Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model.","volume":"93","author":"Matkovic","year":"1994","journal-title":"J Clin Invest"},{"key":"R4-20230912","first-page":"172","article-title":"Bone metabolism in children and adolescents: main characteristics of the determinants of peak bone mass.","volume":"10","author":"Stagi","year":"2013","journal-title":"Clin Cases Miner Bone Metab"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1210\/jc.2003-030767","article-title":"Longitudinal changes of bone mineral density and metabolism in antiretroviral-treated human immunodeficiency virus-infected children.","volume":"89","author":"Mora","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00042560-200204150-00004","article-title":"Bone mineral content is lower in prepubertal HIV-infected children.","volume":"29","author":"Arpadi","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/aid.2005.21.927","article-title":"Bone quality in perinatally HIV-infected children: role of age, sex, growth, HIV infection, and antiretroviral therapy.","volume":"21","author":"Rosso","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/QAI.0b013e31826ea89b","article-title":"Prevalence and risk factors of low bone mineral density among perinatally HIV-infected Thai adolescents receiving antiretroviral therapy.","volume":"61","author":"Puthanakit","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","article-title":"HIV infection, inflammation, immunosenescence, and aging.","volume":"62","author":"Deeks","year":"2011","journal-title":"Annu Rev Med"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11904-009-0038-4","article-title":"Early immune senescence in HIV disease.","volume":"7","author":"Desai","year":"2010","journal-title":"Curr HIV\/AIDS Rep"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences.","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1479-5876-11-51","article-title":"Association between peripheral T-lymphocyte activation and impaired bone mineral density in HIV-infected patients.","volume":"11","author":"Gazzola","year":"2013","journal-title":"J Transl Med"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2334-13-2","article-title":"A new tool for the paediatric HIV research: general data from the Cohort of the Spanish Paediatric HIV Network (CoRISpe).","volume":"13","author":"de Jose","year":"2013","journal-title":"BMC Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/aid.2009.0122","article-title":"Pediatric HIV BioBank: a new role of the Spanish HIV BioBank in pediatric HIV research.","volume":"26","author":"Garc\u00eda-Merino","year":"2010","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1203\/00006450-199403000-00018","article-title":"Bone mineral density of the lumbar spine in white Mediterranean Spanish children and adolescents: changes related to age, sex, and puberty.","volume":"35","author":"del Rio","year":"1994","journal-title":"Pediatr Res"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study.","volume":"96","author":"Zemel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jocd.2014.01.007","article-title":"2013 Pediatric Position Development Conference: executive summary and reflections.","volume":"17","author":"Gordon","year":"2014","journal-title":"J Clin Densitom"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/01.aids.0000131334.38172.01","article-title":"Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV-infected children in Europe.","volume":"18","year":"2004","journal-title":"AIDS"},{"issue":"No RR-12","key":"R20-20230912","article-title":"1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age.","volume":"43","year":"1994","journal-title":"MMWR"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cid\/cis917","article-title":"Bone mineral density increases in HIV-infected children treated with long-term combination antiretroviral therapy.","volume":"56","author":"Bunders","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"e872","DOI":"10.1016\/j.ijid.2012.07.019","article-title":"Factors associated with low bone mineral density in a Brazilian cohort of vertically HIV-infected adolescents.","volume":"16","author":"Schtscherbyna","year":"2012","journal-title":"Int J Infect Dis"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/QAD.0b013e32835a9b80","article-title":"Bone mineral density in children and adolescents with perinatal HIV infection.","volume":"27","author":"DiMeglio","year":"2013","journal-title":"AIDS"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocd.2007.12.005","article-title":"Dual energy x-ray absorptiometry interpretation and reporting in children and adolescents: the 2007 ISCD Pediatric Official Positions.","volume":"11","author":"Gordon","year":"2008","journal-title":"J Clin Densitom"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00198-005-1849-9","article-title":"Bone measures in HIV-1 infected children and adolescents: disparity between quantitative computed tomography and dual-energy x-ray absorptiometry measurements.","volume":"16","author":"Pitukcheewanont","year":"2005","journal-title":"Osteoporos Int"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.mpg.0000174468.75219.30","article-title":"Predictors of bone mineral density in human immunodeficiency virus-1 infected children.","volume":"41","author":"Jacobson","year":"2005","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers.","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen.","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1210\/jc.2011-0591","article-title":"Stable bone density in HAART-treated individuals with HIV: a meta-analysis.","volume":"96","author":"Bolland","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"905","DOI":"10.3851\/IMP2667","article-title":"96-Week results of abacavir\/lamivudine versus tenofovir\/emtricitabine, plus efavirenz, in antiretroviral-naive, HIV-1-infected adults: ASSERT study.","volume":"18","author":"Moyle","year":"2013","journal-title":"Antivir Ther"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","article-title":"Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.","volume":"26","author":"Bedimo","year":"2012","journal-title":"AIDS"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/INF.0000000000000649","article-title":"Long-term efficacy and safety of tenofovir disoproxil fumarate in HIV-1-infected adolescents failing antiretroviral therapy: the final results of study GS-US-104-0321.","volume":"34","author":"Della Negra","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/INF.0000000000000633","article-title":"Efficacy, safety and pharmacokinetics of tenofovir disoproxil fumarate in virologic-suppressed HIV-infected children using weight-band dosing.","volume":"34","author":"Aurpibul","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-2525","article-title":"Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.","volume":"118","author":"Gafni","year":"2006","journal-title":"Pediatrics"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3851\/IMP1650","article-title":"Tenofovir disoproxil fumarate and bone mineral density: a 60-month longitudinal study in a cohort of HIV-infected youths.","volume":"15","author":"Vigan\u00f2","year":"2010","journal-title":"Antivir Ther"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00705-004-0395-7","article-title":"HIV-1 Vpr enhances production of receptor of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity.","volume":"150","author":"Fakruddin","year":"2005","journal-title":"Arch Virol"},{"key":"R38-20230912","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1089\/aid.2007.0112","article-title":"HIV proteins regulate bone marker secretion and transcription factor activity in cultured human osteoblasts with consequent potential implications for osteoblast function and development.","volume":"23","author":"Cotter","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R39-20230912","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/01.qai.0000435598.20104.d6","article-title":"Peak bone mass in young HIV-infected patients compared with healthy controls.","volume":"65","author":"Negredo","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R40-20230912","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e3282f423dd","article-title":"Reduced bone mineral density in HIV-infected patients: prevalence and associated factors.","volume":"22","author":"Cazanave","year":"2008","journal-title":"AIDS"},{"key":"R41-20230912","doi-asserted-by":"crossref","first-page":"e30307","DOI":"10.1371\/journal.pone.0030307","article-title":"HIV-induced T-cell activation\/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment.","volume":"7","author":"Rueda","year":"2012","journal-title":"PLoS One"},{"key":"R42-20230912","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1359\/jbmr.2001.16.2.328","article-title":"T cell activation induces human osteoclast formation via receptor activator of nuclear factor kappaB ligand-dependent and -independent mechanisms.","volume":"16","author":"Weitzmann","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R43-20230912","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1097\/QAI.0b013e318259254f","article-title":"Detectable viral load aggravates immunosenescence features of CD8 T-cell subsets in vertically HIV-infected children.","volume":"60","author":"D\u00edaz","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R44-20230912","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1469-0691.2012.03934.x","article-title":"Specific patterns of CD4-associated immunosenescence in vertically HIV-infected subjects.","volume":"19","author":"M\u00e9ndez-Lagares","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"R45-20230912","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QAI.0000000000000005","article-title":"Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.","volume":"65","author":"Erlandson","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R46-20230912","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1097\/INF.0b013e3182a735ed","article-title":"Vitamin D deficiency and insufficiency in HIV-infected children and young adults.","volume":"32","author":"Meyzer","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"R47-20230912","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3945\/ajcn.111.024786","article-title":"Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial.","volume":"95","author":"Arpadi","year":"2012","journal-title":"Am J Clin Nutr"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-201706000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:26:04Z","timestamp":1786047964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-201706000-00009"}},"subtitle":["Risk Factors and the Role of T-cell Activation and Senescence"],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000001506","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}